Advanced Hepatocellular Carcinoma
Showing 1 - 25 of 86
Advanced Hepatocellular Carcinoma Trial in Beijing (Neoantigen vaccine, I.M injection)
Recruiting
- Advanced Hepatocellular Carcinoma
- Neoantigen vaccine, I.M injection
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jul 31, 2023
Advanced Hepatocellular Carcinoma Trial in China (Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules)
Recruiting
- Advanced Hepatocellular Carcinoma
- Penpulimab injection
- +2 more
-
Wuwei, Gansu, China
- +7 more
Jul 27, 2023
Advanced Hepatocellular Carcinoma Trial in Guangzhou (adebrelimab, camrelizumab plus apatinib)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- adebrelimab, camrelizumab plus apatinib
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Jun 21, 2023
Advanced Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
-
La Jolla, California
- +46 more
May 22, 2023
Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- SZ003 CAR-NK
- (no location specified)
Apr 25, 2023
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- (no location specified)
Mar 21, 2023
Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- EU307 CAR-T Cell
- (no location specified)
Mar 13, 2023
Advanced Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab+regorafenib)
Active, not recruiting
- Advanced Hepatocellular Carcinoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 6, 2023
Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)
Recruiting
- Advanced Hepatocellular Carcinoma
- Lenvatinib combined with TACE and Camrelizumab
-
Chengdu, Sichuan, ChinaHuaXi hospital
Feb 12, 2023
Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Lenvatinib
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023
Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Hepatocellular Carcinoma
- +4 more
- Futibatinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Advanced Hepatocellular Carcinoma Trial in Hangzhou (CT0180 Cells)
Recruiting
- Advanced Hepatocellular Carcinoma
- CT0180 Cells
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
Jan 27, 2023
Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)
Withdrawn
- Advanced Hepatocellular Carcinoma
- GDKM-100 injection
-
Zhuhai, Guangdong, ChinaZhuhai People'S Hospital
Jan 16, 2023
Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)
Recruiting
- Advanced Hepatocellular Carcinoma
- GPC3 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)
Recruiting
- Advanced Hepatocellular Carcinoma
- Bifidobacterium Bifidum Oral Product
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022
Advanced Hepatocellular Carcinoma Trial in Shanghai (Tislelizumab, lenvatinib, US/CT-guided Percutaneous Cryoablation)
Recruiting
- Advanced Hepatocellular Carcinoma
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 8, 2022
Atezolizumab Plus Bevacizumab in Advanced HCC
Recruiting
- Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCha Medical Center
Oct 30, 2022
Advanced Hepatocellular Carcinoma Trial (Sorafenib)
Enrolling by invitation
- Advanced Hepatocellular Carcinoma
-
Seoul, Korea, Republic ofNational Cancer Center, Korea
Oct 19, 2022
Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)
Recruiting
- Advanced Hepatocellular Carcinoma
- Lenvatinib
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022
Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)
Recruiting
- Hepatocellular Carcinoma
- Advanced Hepatocellular Carcinoma
- ADI-PEG20
- Placebo
-
Changhua, Taiwan
- +8 more
Oct 19, 2022
Advanced Hepatocellular Carcinoma Trial in Shanghai (Biological/Vaccine: Low-dose group, Biological/Vaccine: Mid-dose group,
Recruiting
- Advanced Hepatocellular Carcinoma
- Biological/Vaccine: Low-dose group
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Jul 27, 2022
Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle
Terminated
- Advanced Hepatocellular Carcinoma
- +2 more
- Cabozantinib S-malate
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 12, 2022
Advanced Hepatocellular Carcinoma Trial in London (Itacitinib (INCB039110))
Recruiting
- Advanced Hepatocellular Carcinoma
- Itacitinib (INCB039110)
-
London, United KingdomImperial College Healthcare NHS Trust
Jul 14, 2022